ArticleInternational ophthalmology2024
Exploration of AI-powered DenseNet121 for effective diabetic retinopathy detection.
Article in International ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.
- Diagnostic Accuracy of AI in Prediction and Assessment of Compromised Free Flaps: Systematic Review and Meta-Analysis.Journal of medical Internet research · 2026Pooled it
- Comparing Deep Learning Models for Identifying Maxillary Transverse Deficiency from Intraoral Photographs.International dental journal · 2026Article
- A hybrid dual-stream CNN framework with dynamic data augmentation and improved Manta Ray Foraging Optimization for robust glaucoma detection.Scientific reports · 2026Article
- Artificial intelligence in mobile health applications: A comprehensive review of its role in diabetes care.World journal of methodology · 2026Review
- Fundus Image Deep Learning Study to Explore the Association of Retinal Morphology with Age-Related Macular Degeneration Polygenic Risk Score.Biomedicines · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveDiabetic Retinopathy (DR) is a severe complication of diabetes that damages the retina and affects approximately 80% of patients with diabetes for 10 years or more. This condition primarily impacts young and productive individuals, resulting in significant long-term medical complications for patients and society. The early stages of diabetic retinopathy often advance without noticeable symptoms, resulting in delayed identification and intervention. Therefore, develop approaches employing transfer learning methodologies to enhance early detection capabilities, facilitating timely diagnosis and intervention to mitigate the progression of diabetic retinopathy.
methodsThis study introduces a transfer learning approach for detecting four stages of DR: No DR, Mild, Moderate, and Severe. The methods AlexNet, VGG16, ResNet50, Inception v3, and DenseNet121 are utilized and trained using the Kaggle DR dataset.
resultsTo assess the efficiency of the suggested improved network, the Kaggle dataset is employed to analyze four performance metrics: Sensitivity, Precision, Accuracy, and F1 score. DenseNet121 demonstrated superior accuracy among the two models, outperforming other models, making it a suitable option for automatic DR sign detection.
conclusionThe integration of the DenseNet121 model shows great promise in transforming the timely identification and treatment of DR, resulting in enhanced patient results in the long run and alleviating the burden on society.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.